AMY L. BARRACLOUGH PA-C
Prescription History 1770533713
Physician Assistant in Portland, ME
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for AMY L. BARRACLOUGH PA-C, an active Physician Assistant specialist practicing in Portland, ME. Our medical registry currently tracks 10 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 456 documented patient claims. Among these therapy options, the most frequently utilized medication is Paxlovid, which accounts for 181 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other ME PrescribersVs. ME Avg |
|---|---|---|---|
| PaxlovidNirmatrelvir/Ritonavir | 181 | $31.58▼ below ME avg | ▲ More than typical |
About Paxlovid: This combination of nirmatrelvir and ritonavir is used to treat coronavirus disease (COVID-19) in people who have mild to moderate symptoms and have a high risk for COVID-19 complications. Show more ▾ It helps people who have COVID-19 to stay out of the hospital. It is not for use by people who are hospitalized due to COVID-19. Nirmatrelvir is a SARS-CoV-2 main protease inhibitor. It works by preventing the growth of the virus that causes COVID-19. Ritonavir increases ("boosts") the levels of nirmatrelvir. This helps nirmatrelvir work better. This medication works by stopping the coronavirus from growing. It cannot be used to prevent COVID-19. In 2024, this provider wrote 181 Medicare prescriptions for Paxlovid, about 9.5 times the volume of the typical Maine prescriber of this medication (19.1). Medicare paid an average of $31.58 per fill, versus $32.18 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 181 30-Day Fills standardized to 30-day supplies 905 Days of Medication total across all patients in 2024 | |||
| Doxycycline Monohydrate | 64 | $11.39▼ below ME avg | ▲ More than typical |
About Doxycycline Monohydrate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2024, this provider wrote 64 Medicare prescriptions for Doxycycline Monohydrate, about 2.5 times the volume of the typical Maine prescriber of this medication (25.6). Medicare paid an average of $11.39 per fill, versus $14.74 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 64 30-Day Fills standardized to 30-day supplies 428 Days of Medication total across all patients in 2024 | |||
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 63 | $8.80▼ below ME avg | ▲ More than typical |
About Amoxicillin-Clavulanate Potass: Amoxicillin/clavulanic acid is a combination penicillin-type antibiotic used to treat a wide variety of bacterial infections. Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. In 2024, this provider wrote 63 Medicare prescriptions for Amoxicillin-Clavulanate Potass, about 2.8 times the volume of the typical Maine prescriber of this medication (22.2). Medicare paid an average of $8.80 per fill, versus $10.10 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 63 30-Day Fills standardized to 30-day supplies 449 Days of Medication total across all patients in 2024 | |||
| Prednisone | 40 | $1.50▼ below ME avg | ≈ Typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2024, this provider wrote 40 Medicare prescriptions for Prednisone, about the same volume as the typical Maine prescriber of this medication (42.4). Medicare paid an average of $1.50 per fill, versus $3.61 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 40 30-Day Fills standardized to 30-day supplies 268 Days of Medication total across all patients in 2024 | |||
| Cephalexin | 22 | $6.43▼ below ME avg | ≈ Typical |
About Cephalexin: This medication is used to treat a wide variety of bacterial infections. Show more ▾ This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. In 2024, this provider wrote 22 Medicare prescriptions for Cephalexin, about the same volume as the typical Maine prescriber of this medication (24). Medicare paid an average of $6.43 per fill, versus $8.17 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 22 30-Day Fills standardized to 30-day supplies 142 Days of Medication total across all patients in 2024 | |||
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 22 | $8.62▼ below ME avg | ≈ Typical |
About Nitrofurantoin Mono-Macro: This medication is an antibiotic used to treat bladder infections (acute cystitis). Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. This medication should not be used in infants younger than 1 month old (see also Precautions section). This drug should not be used to treat infections outside the bladder (including kidney infections such as pyelonephritis or perinephric abscesses). In 2024, this provider wrote 22 Medicare prescriptions for Nitrofurantoin Mono-Macro, about the same volume as the typical Maine prescriber of this medication (20.3). Medicare paid an average of $8.62 per fill, versus $15.61 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 22 30-Day Fills standardized to 30-day supplies 114 Days of Medication total across all patients in 2024 | |||
| Paxlovid (Eua)Nirmatrelvir/Ritonavir | 22 | $10.61 | – No State Data |
About Paxlovid (Eua): This combination of nirmatrelvir and ritonavir is used to treat coronavirus disease (COVID-19) in people who have mild to moderate symptoms and have a high risk for COVID-19 complications. Show more ▾ It helps people who have COVID-19 to stay out of the hospital. It is not for use by people who are hospitalized due to COVID-19. Nirmatrelvir is a SARS-CoV-2 main protease inhibitor. It works by preventing the growth of the virus that causes COVID-19. Ritonavir increases ("boosts") the levels of nirmatrelvir. This helps nirmatrelvir work better. This medication works by stopping the coronavirus from growing. It cannot be used to prevent COVID-19. In 2024, this provider wrote 22 Medicare prescriptions for Paxlovid (Eua). Medicare paid an average of $10.61 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $10.61 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22 30-Day Fills standardized to 30-day supplies 110 Days of Medication total across all patients in 2024 | |||
| Azithromycin | 15 | $5.18▼ below ME avg | ▼ Less than typical |
About Azithromycin: Azithromycin is used to treat a wide variety of bacterial infections. Show more ▾ It is a macrolide-type antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis. In 2024, this provider wrote 15 Medicare prescriptions for Azithromycin, about 61% of the volume of the typical Maine prescriber of this medication (24.8). Medicare paid an average of $5.18 per fill, versus $6.23 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 15 30-Day Fills standardized to 30-day supplies 77 Days of Medication total across all patients in 2024 | |||
| Lagevrio (Eua)Molnupiravir | 15 | $439.40▼ below ME avg | ≈ Typical |
About Lagevrio (Eua): Molnupiravir is a product that the FDA is allowing to be given for emergency use to treat COVID-19. Show more ▾ It is used by adults 18 years of age and older who have had mild to moderate symptoms for no more than 5 days and are not hospitalized. To receive this product you must also be at high risk for COVID-19 complications due to older age, obesity, or ongoing medical conditions (such as lung or heart disease or diabetes, among others). Talk to your doctor about the risks and benefits of treatment with molnupiravir. Molnupiravir works by preventing the growth of the virus that causes COVID-19. More information about molnupiravir is available from the FDA Fact Sheet for Patients, Parents, and Caregivers for Emergency Use. There is limited information about how safe and effective molnupiravir is for treating COVID-19. Study results show that molnupiravir may help people who have coronavirus stay out of the hospital. This product is not for use by people who are hospitalized due to COVID-19. The information in this document reflects emerging data, which is evolving and subject to reassessment. Users should be aware of these considerations in their review of molnupiravir, and it is always the responsibility of treating practitioners to exercise independent judgement in making care decisions. Prodrug that’s metabolized into N4-hydroxycytidine (NHC), a ribonucleoside analog. In 2024, this provider wrote 15 Medicare prescriptions for Lagevrio (Eua), about the same volume as the typical Maine prescriber of this medication (15.1). Medicare paid an average of $439.40 per fill, versus $570.37 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 15 30-Day Fills standardized to 30-day supplies 75 Days of Medication total across all patients in 2024 | |||
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 12 | $6.35 | ▼ Less than typical |
About Polymyxin B Sul-Trimethoprim: This medication is used to treat bacterial infections (such as blepharitis, conjunctivitis) of the eye. Show more ▾ It contains 2 antibiotics. Polymyxin B works by killing the bacteria. Trimethoprim works by stopping the growth of the bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. In 2024, this provider wrote 12 Medicare prescriptions for Polymyxin B Sul-Trimethoprim, about 60% of the volume of the typical Maine prescriber of this medication (19.9). Medicare paid an average of $6.35 per fill, versus $6.11 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 14 30-Day Fills standardized to 30-day supplies 300 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for AMY L. BARRACLOUGH PA-C is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Physician Assistant prescribing approach at this Portland, ME practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among ME prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
